Publication | Closed Access

Perioperative sargramostim (recombinant human GM-CSF) induces an increase in the level of soluble VEGFR1 in colon cancer patients undergoing minimally invasive surgery

Colon Cancer PatientsSurgical OncologySoluble Vegfr1Perioperative SargramostimGastrointestinal OncologyMedicineImmunologyColorectal CancerPathologyOncologyRadiation OncologyCancer Research